MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 49 filers reported holding MYMD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,463 | -64.2% | 32,877 | -9.3% | 0.00% | – |
| Q2 2023 | $54,392 | -0.3% | 36,261 | +14.4% | 0.00% | – |
| Q1 2023 | $54,536 | +601.5% | 31,707 | +369.0% | 0.00% | – |
| Q4 2022 | $7,774 | +55.5% | 6,760 | +249.9% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 1,932 | -18.9% | 0.00% | – |
| Q2 2022 | $5,000 | -64.3% | 2,382 | -22.7% | 0.00% | – |
| Q1 2022 | $14,000 | -44.0% | 3,082 | -24.5% | 0.00% | – |
| Q4 2021 | $25,000 | +1150.0% | 4,082 | +1363.1% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 279 | +39.5% | 0.00% | – |
| Q2 2021 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 321,187 | $1,497,000 | 0.19% |
| Corundum Group, Inc. | 19,600 | $91,000 | 0.08% |
| Ikarian Capital, LLC | 131,389 | $612,000 | 0.08% |
| M Holdings Securities, Inc. | 70,909 | $330,000 | 0.02% |
| 683 Capital Management, LLC | 59,410 | $277,000 | 0.02% |
| Western Wealth Management, LLC | 30,713 | $143,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,095,418 | $5,104,000 | 0.01% |
| Qube Research & Technologies Ltd | 20,896 | $97,000 | 0.00% |
| MORGAN STANLEY | 908,576 | $4,234,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,690 | $64,000 | 0.00% |